- Home
- MBLY vs NBIX Comparison
MBLY vs NBIX Comparison
Compare MBLY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBLY
- NBIX
- Stock Information
- Founded
- MBLY 1999
- NBIX 1992
- Country
- MBLY Israel
- NBIX United States
- Employees
- MBLY N/A
- NBIX N/A
- Industry
- MBLY Computer Software: Prepackaged Software
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MBLY Technology
- NBIX Health Care
- Exchange
- MBLY Nasdaq
- NBIX Nasdaq
- Market Cap
- MBLY 11.8B
- NBIX 12.0B
- IPO Year
- MBLY 2022
- NBIX 1996
- Fundamental
- Price
- MBLY $15.96
- NBIX $121.02
- Analyst Decision
- MBLY Buy
- NBIX Strong Buy
- Analyst Count
- MBLY 20
- NBIX 20
- Target Price
- MBLY $19.33
- NBIX $163.20
- AVG Volume (30 Days)
- MBLY 3.3M
- NBIX 1.7M
- Earning Date
- MBLY 04-24-2025
- NBIX 05-05-2025
- Dividend Yield
- MBLY N/A
- NBIX N/A
- EPS Growth
- MBLY N/A
- NBIX N/A
- EPS
- MBLY N/A
- NBIX 2.96
- Revenue
- MBLY $1,853,000,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- MBLY $7.26
- NBIX $15.74
- Revenue Next Year
- MBLY $14.94
- NBIX $15.22
- P/E Ratio
- MBLY N/A
- NBIX $40.90
- Revenue Growth
- MBLY N/A
- NBIX 21.73
- 52 Week Low
- MBLY $10.48
- NBIX $84.23
- 52 Week High
- MBLY $33.26
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- MBLY 58.03
- NBIX 64.15
- Support Level
- MBLY $16.39
- NBIX $116.00
- Resistance Level
- MBLY $17.49
- NBIX $121.85
- Average True Range (ATR)
- MBLY 0.66
- NBIX 4.43
- MACD
- MBLY 0.19
- NBIX 1.12
- Stochastic Oscillator
- MBLY 54.11
- NBIX 62.69
About MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Others. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.